Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Registry of Spectral Angio-CT-Guided Interventional Oncology Procedures in Routine Clinical Practice

NCT07636148 is registered in ClinicalTrials.gov with Mark C Burgmans, MD PhD as lead sponsor.

NCT NCT07636148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07636148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Registry of Spectral Angio-CT-Guided Interventional Oncology Procedures in Routine Clinical Practice
Lead sponsor
Mark C Burgmans, MD PhD
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2026
Completion date
December 31, 2030
Enrollment
2,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bone cancer metastatic, bone cancer tumor, bone tumors, hepatocellular carcinoma (hcc), kidney tumors, liver cancer (primary and metastatic), lung cancer (diagnosis), lung tumors, musculoskeletal cancers, musculoskeletal tumors, renal cancer, renal cell carcinoma (kidney cancer), renal cell carcinoma (rcc)